A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Clinical trial NCT01316822 · COMPLETED
Trial details
- NCT number
- NCT01316822
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.